Inflammatory carcinoma of the breast

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Alkylating agent 1 substance
Checkpoint inhibitor (PD-1) 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Istituto Europeo Di Oncologia S.r.l. Academic
    CYCLOPHOSPHAMIDE MONOHYDRATE; PEMBROLIZUMAB
    2023-507365-26-00 1 country 2020 n=46
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Istituto Europeo Di Oncologia S.r.l. Academic 1 Phase II 0
New trials by year
2020
1
← All indication landscapes